Market Capitalization:2 459 011 936 127 USD
Vol. in 24 hours:112 927 103 627,78 USD
Dominance:BTC 58,91%
ETH:10,46%
Market Capitalization:2 459 011 936 127 USD
Vol. in 24 hours:112 927 103 627,78 USD
Dominance:BTC 58,91%
ETH:10,46%
Market Capitalization:2 459 011 936 127 USD
Vol. in 24 hours:112 927 103 627,78 USD
Dominance:BTC 58,91%
ETH:10,46%
Market Capitalization:2 459 011 936 127 USD
Vol. in 24 hours:112 927 103 627,78 USD
Dominance:BTC 58,91%
ETH:10,46%
Market Capitalization:2 459 011 936 127 USD
Vol. in 24 hours:112 927 103 627,78 USD
Dominance:BTC 58,91%
ETH:10,46%
Market Capitalization:2 459 011 936 127 USD
Vol. in 24 hours:112 927 103 627,78 USD
Dominance:BTC 58,91%
ETH:10,46%
Market Capitalization:2 459 011 936 127 USD
Vol. in 24 hours:112 927 103 627,78 USD
Dominance:BTC 58,91%
ETH:10,46%
Market Capitalization:2 459 011 936 127 USD
Vol. in 24 hours:112 927 103 627,78 USD
Dominance:BTC 58,91%
ETH:10,46%
Market Capitalization:2 459 011 936 127 USD
Vol. in 24 hours:112 927 103 627,78 USD
Dominance:BTC 58,91%
ETH:10,46%
Market Capitalization:2 459 011 936 127 USD
Vol. in 24 hours:112 927 103 627,78 USD
Dominance:BTC 58,91%
ETH:10,46%
Yes

Nakamoto, a Bitcoin treasury firm, falls nearly 10% after announcing its name change.

crypthub
Nakamoto, a Bitcoin treasury firm, falls nearly 10% after announcing its name change.

Rebranding and Immediate Market Response

The firm announced a name change from KindlyMD to Nakamoto Inc., adopting the ticker NAKA. The new brand signals an exclusive focus on Bitcoin reserves. Following the announcement, the stock slipped more than 7% during trading, ending around $0.39, a near‑10% drop from the previous day.

Strategic Shift Toward Bitcoin

CEO David Bailey said the rebrand removes ambiguity and aligns the company with its Bitcoin‑centric mission. Nakamoto now holds over $500 million in Bitcoin and plans to acquire up to 5% of the total 21 million coins. The move follows a wave of corporate treasury strategies that prioritize digital assets.

Investor Sentiment and Outlook

Investors reacted skeptically, fearing the firm may struggle to balance its legacy medical services with the new crypto focus. Shares traded far below the May high of $25, and a modest revenue miss heightened concerns. Analysts project a target price near $1.25, watching how Bitcoin price swings affect the company’s balance sheet.